This is one of the great business leaders leading in real time unscripted on the topic of work from home. He is entirely right.
We can all learn from him. A must listen.
🧵Congrats to three of our superstar cardiology fellows @YaleCardiology who will be joining our EP Family at Yale for next 2 years.
Cannot wait to tackle more AF, SVT, PVC, VTs, EGMs and device cases together next year🚀 Kene, Camila, and Giorgi- welcome to EP⚡️
@DrKene@camilatrejop@rraven8@ajkadado @SethFakess #Epeeps #CardioTwitter
With up to 32% early post-procedural mortality, VT ablation in the emergency setting is among the highest risk procedures in cardiology and cardiothoracic surgery.
Read the Vanderbilt experience (https://t.co/TO6ePj4vPh) and our commentary (https://t.co/gc5NW7kog6) @shivkumarmd
After 2 months of embargo for #AHA24 Late Breaking presentation, we are pleased to announce PanEcho - Complete AI-enabled echocardiography interpretation with multi-task deep learning
Led by @giholste & @ekoikonomou@cards_lab
Preprint, code, model here: https://t.co/lxBuu8NkTD
Presented at #AHA24:
Among patients with ventricular tachycardia and ischemic cardiomyopathy, catheter ablation as an initial therapy led to a lower risk of adverse outcomes than antiarrhythmic drug therapy. Read the full VANISH2 trial results: https://t.co/yDFhCI9KNA
🧵1/Left Ventricular Activation Time (LVAT) Explained!
Measured time between Stim and peak R-wave in leads V5 or V6.
•LVAT <80 indicates good LV synchrony
•LVAT <80 indicates LB capture during LB pacing
•Prolonged LVAT associated with increased mortality in HF patients
In CRT, where the goal is to improve ventricular synchrony, a short LVAT is crucial for optimal therapeutic benefit.
#EPeeps #Cardiotwitter
@ruey_hu@INS_ESV@YaleCardiology Thanks @ruey_hu for accepting to collaborate! I am sure your tools will be more than useful in this setting. Looking forward for your talk!